Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1902 1
1903 1
1905 1
1909 1
1911 1
1918 1
1920 1
1928 1
1929 1
1934 1
1936 1
1937 2
1940 1
1942 1
1944 1
1945 4
1946 5
1947 18
1948 11
1949 8
1950 21
1951 42
1952 24
1953 36
1954 37
1955 48
1956 52
1957 55
1958 66
1959 61
1960 65
1961 53
1962 53
1963 179
1964 277
1965 187
1966 179
1967 182
1968 264
1969 296
1970 347
1971 450
1972 453
1973 559
1974 626
1975 680
1976 726
1977 707
1978 731
1979 762
1980 874
1981 890
1982 827
1983 911
1984 869
1985 900
1986 945
1987 876
1988 813
1989 908
1990 929
1991 987
1992 1024
1993 1015
1994 1092
1995 1077
1996 1135
1997 1169
1998 1275
1999 1360
2000 1435
2001 1449
2002 1498
2003 1767
2004 1760
2005 1845
2006 2025
2007 2026
2008 2015
2009 2081
2010 2193
2011 2261
2012 2419
2013 2445
2014 2486
2015 2512
2016 2418
2017 2301
2018 2365
2019 2472
2020 2747
2021 2765
2022 2445
2023 2252
2024 1733

Text availability

Article attribute

Article type

Publication date

Search Results

76,362 results

Results by year

Filters applied: . Clear all
Page 1
Aspirin in Primary Prevention of Cardiovascular Events.
Soodi D, VanWormer JJ, Rezkalla SH. Soodi D, et al. Clin Med Res. 2020 Aug;18(2-3):89-94. doi: 10.3121/cmr.2020.1548. Epub 2020 Jun 24. Clin Med Res. 2020. PMID: 32580960 Free PMC article. Review.
Aspirin has demonstrated a clear benefit in secondary prevention of coronary syndrome, while aspirin's effect in primary prevention is unclear. ...A thoughtful discussion between patients and their doctors should be conducted before beginning aspirin u …
Aspirin has demonstrated a clear benefit in secondary prevention of coronary syndrome, while aspirin's effect in primar …
Aspirin and its pleiotropic application.
Hybiak J, Broniarek I, Kiryczyński G, Los LD, Rosik J, Machaj F, Sławiński H, Jankowska K, Urasińska E. Hybiak J, et al. Eur J Pharmacol. 2020 Jan 5;866:172762. doi: 10.1016/j.ejphar.2019.172762. Epub 2019 Oct 26. Eur J Pharmacol. 2020. PMID: 31669590 Review.
Its function as an anticoagulant has also been explored in the prophylaxis and treatment of pre-eclampsia, where due to its anti-inflammatory properties, aspirin intake may be used to reduce the risk of colorectal cancer. It is important to always consider both the risks a …
Its function as an anticoagulant has also been explored in the prophylaxis and treatment of pre-eclampsia, where due to its anti-inflammator …
Aspirin in the Modern Era of Cardiovascular Disease Prevention.
Murphy E, Curneen JMG, McEvoy JW. Murphy E, et al. Methodist Debakey Cardiovasc J. 2021 Sep 24;17(4):36-47. doi: 10.14797/mdcvj.293. eCollection 2021. Methodist Debakey Cardiovasc J. 2021. PMID: 34824680 Free PMC article. Review.
Aspirin's antithrombotic effects have a long-established place in the prevention of cardiovascular disease (CVD), and its traditional use as a core therapy for secondary prevention of CVD is well recognized. However, with the advent of newer antiplatelet agents and …
Aspirin's antithrombotic effects have a long-established place in the prevention of cardiovascular disease (CVD), and its trad …
Aspirin and colorectal cancer: the promise of precision chemoprevention.
Drew DA, Cao Y, Chan AT. Drew DA, et al. Nat Rev Cancer. 2016 Mar;16(3):173-86. doi: 10.1038/nrc.2016.4. Epub 2016 Feb 12. Nat Rev Cancer. 2016. PMID: 26868177 Free PMC article. Review.
Several decades of research have provided considerable evidence demonstrating its potential for the prevention of cancer, particularly colorectal cancer. Broader clinical recommendations for aspirin-based chemoprevention strategies have recently been established; however, …
Several decades of research have provided considerable evidence demonstrating its potential for the prevention of cancer, particularly color …
Use of aspirin to reduce risk of initial vascular events in patients at moderate risk of cardiovascular disease (ARRIVE): a randomised, double-blind, placebo-controlled trial.
Gaziano JM, Brotons C, Coppolecchia R, Cricelli C, Darius H, Gorelick PB, Howard G, Pearson TA, Rothwell PM, Ruilope LM, Tendera M, Tognoni G; ARRIVE Executive Committee. Gaziano JM, et al. Lancet. 2018 Sep 22;392(10152):1036-1046. doi: 10.1016/S0140-6736(18)31924-X. Epub 2018 Aug 26. Lancet. 2018. PMID: 30158069 Free PMC article. Clinical Trial.
BACKGROUND: The use of aspirin in the primary prevention of cardiovascular events remains controversial. We aimed to assess the efficacy and safety of aspirin versus placebo in patients with a moderate estimated risk of a first cardiovascular event. ...Nonetheless, …
BACKGROUND: The use of aspirin in the primary prevention of cardiovascular events remains controversial. We aimed to assess the effic …
Aspirine ou clopidogrel ? Le débat continue.
Abellan C. Abellan C. Rev Med Suisse. 2023 Apr 12;19(822):739. doi: 10.53738/REVMED.2023.19.822.739. Rev Med Suisse. 2023. PMID: 37057858 French. No abstract available.
Association of aspirin with all-cause and cardiocerebrovascular mortality in patients with metabolic associated fatty liver disease.
Chen Z, Chen M, Zeng P, Yang X, Li Q. Chen Z, et al. Scand J Gastroenterol. 2023 Jul-Dec;58(8):908-914. doi: 10.1080/00365521.2023.2179864. Epub 2023 Feb 17. Scand J Gastroenterol. 2023. PMID: 36799202
BACKGROUND: Studies on aspirin's effects on metabolic-associated fatty liver disease (MAFLD) are limited. The aim of this study was to assess the association between aspirin and all-cause and cardiovascular disease (CVD) mortality in individuals with MAFLD. . …
BACKGROUND: Studies on aspirin's effects on metabolic-associated fatty liver disease (MAFLD) are limited. The aim of this stud …
Low-dose aspirin for the prevention of atherosclerotic cardiovascular disease.
Patrono C. Patrono C. Eur Heart J. 2024 Jul 12;45(27):2362-2376. doi: 10.1093/eurheartj/ehae324. Eur Heart J. 2024. PMID: 38839268 Free PMC article. Review.
During the past 30 years, several developments have occurred in the antiplatelet field, including the role of aspirin in primary prevention of atherosclerotic cardiovascular disease. There have been several attempts to develop antiplatelet drugs more effective and safer th …
During the past 30 years, several developments have occurred in the antiplatelet field, including the role of aspirin in primary prev …
Aspirin resistance.
Howard PA. Howard PA. Ann Pharmacother. 2002 Oct;36(10):1620-4. doi: 10.1345/aph.1C013. Ann Pharmacother. 2002. PMID: 12243613 Review.
The studies to date have failed to demonstrate consistent relationships between aspirin's platelet-inhibiting effects, the impact of dosage escalation, and clinical outcomes. CONCLUSIONS: For many patients, aspirin is an effective antithrombotic agent. Howeve …
The studies to date have failed to demonstrate consistent relationships between aspirin's platelet-inhibiting effects, the imp …
The impact of risk factors on aspirin's efficacy for the prevention of preterm birth.
Nuss EE, Hoffman MK, Goudar SS, Kavi A, Metgud M, Somannavar M, Okitawutshu J, Lokangaka A, Tshefu A, Bauserman M, Tembo AM, Chomba E, Carlo WA, Figueroa L, Krebs NF, Jessani S, Saleem S, Goldenberg RL, Kurhe K, Das P, Hibberd PL, Achieng E, Nyongesa P, Esamai F, Liechty EA, Bucher S, Goco N, Hemingway-Foday J, Moore J, McClure EM, Silver RM, Derman RJ; Aspirin Supplementation for Pregnancy Indicated Risk Reduction In Nulliparas Study Group. Nuss EE, et al. Am J Obstet Gynecol MFM. 2023 Oct;5(10):101095. doi: 10.1016/j.ajogmf.2023.101095. Epub 2023 Aug 12. Am J Obstet Gynecol MFM. 2023. PMID: 37574046 Free PMC article. Clinical Trial.
CONCLUSION: Low-dose aspirin's ability to prevent preterm birth, hypertensive disorders of pregnancy, and perinatal mortality was similar in nulliparous women with and without additional risk factors. Professional societies should consider recommending low-dose a …
CONCLUSION: Low-dose aspirin's ability to prevent preterm birth, hypertensive disorders of pregnancy, and perinatal mortality …
76,362 results
You have reached the last available page of results. Please see the User Guide for more information.